Vesselon acquires FDA-approved Lipid Microsphere Drug Imagent for therapeutic platform

Vesselon acquires FDA-approved Lipid Microsphere Drug Imagent for therapeutic platform

Submitted by admin on August 8, 2019 - 11:30pm
Source: 
Pharmaceutical Business Review
News Tags: 
Vesselon
oncology
FDA
Imagent
liquid microspherePH
Headline: 
Vesselon acquires FDA-approved Lipid Microsphere Drug Imagent for therapeutic platform
snippet: 


Vesselon, an oncology therapeutics company, announced the acquisition of an FDA-approved drug Imagent.

Do Not Allow Advertisers to Use My Personal information